Trials / Completed
CompletedNCT03973905
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States: Analysis of a Dataset From a Case-control Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 290 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 2 Days – 2 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to estimate the effectiveness of maternal immunization with Boostrix at preventing pertussis in infants in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable / dataset analysis | Not applicable / dataset analysis |
Timeline
- Start date
- 2019-02-15
- Primary completion
- 2019-05-15
- Completion
- 2019-05-15
- First posted
- 2019-06-04
- Last updated
- 2020-07-07
- Results posted
- 2020-07-07
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03973905. Inclusion in this directory is not an endorsement.